UAE approves Sputnik V vaccine: All you need to know
Published on January 22, 2021 at 07.13
The newest addition makes it the third such vaccine to be approved for use in the UAE after Sinopharm and Pfizer.
In the wake of the recent spike in Covid-19 cases, the UAE has approved Russia’s Sputnik V vaccine for emergency use, as part of comprehensive efforts to ensure residents’ safety.
The Sputnik vaccine, said to be 91.4 per cent effective at protecting people from Covid-19 based on interim results, underwent Phase III trials in the UAE.
About Sputnik vaccine
Sputnik V is a two dose vaccine. The lyophilized (dry) form of the vaccine can be stored at a temperature of +2 to +8 degrees Celsius.
The vaccine is named after the first Soviet space satellite.
The launch of Sputnik-1 in 1957 reinvigorated space research around the world, creating a so called ‘Sputnik moment’ for the global community.
Here’s all you need to know about Sputnik vaccine
>> Sputnik V is the world’s first registered Covid vaccine
>> It has to be given in two doses, with a gap of 21 days
>> It was developed by the Gamaleya National Centre of Epidemiology and Microbiology in Moscow, a state-run research centre
>> It must be stored at -18° Celsius temperature or below, though a lyophilised (dry) form can be stored at a temperature of +2° to +8° Celsius
>> Its post-registration clinical trial in Russia involved 40,000 volunteers
>> Clinical trials were also conducted in the UAE, India, Venezuela and Belarus, Brazil and Egypt
>> The vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials.
>> Its efficacy against severe cases of coronavirus is 100%
>> According to its developers, the vaccine’s side effects include a fever of 38° Celsius, headaches and muscle pain and affect about 15% of recipients